Trial intelligence / Profile preview

Autologous oral mucosal epithelial cell sheets to prevent esophageal stricture after ESD

jRCTb070190053Completed

Sponsor
Okinawa Prefecture
Start
May 2018
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

Open-label, single-arm trial of autologous oral mucosal epithelial cell sheet in Esophageal stricture and esophageal cancer, sponsored by Okinawa Prefecture. Started May 2018; status: completed.

02

Drugs

autologous oral mucosal epithelial cell sheet
03

Conditions

Esophageal strictureesophageal cancer

Beyond the preview

Go deeper on jRCTb070190053.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTb070190053.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call